Lv6
2160 积分 2022-03-21 加入
[177Lu]Lu-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
16天前
已完结
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2 -Negative Breast Cancer
16天前
已完结
The next generation of antibody–drug conjugates
16天前
已完结
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2 -Negative Breast Cancer
23天前
已完结
Beyond Depigmentation: A Cross-Sectional Study of 5227 Chinese Vitiligo Patients
1个月前
已完结
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimetic
1个月前
已关闭
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
2个月前
已完结
It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease
2个月前
已完结
Prevention and Treatment of Peanut Allergy
2个月前
已完结
皖公网安备34019202002308
